{"id":8540,"date":"2026-05-20T05:00:00","date_gmt":"2026-05-20T03:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=322bcbec1ddef2abf3725850d4204f61"},"modified":"2026-05-20T05:00:00","modified_gmt":"2026-05-20T03:00:00","slug":"gehc-investor-alert-kirby-mcinerney-llp-investigates-potential-claims-involving-ge-healthcare-technologies-inc","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=8540","title":{"rendered":"GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc."},"content":{"rendered":"

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP<\/a> continues its investigation on behalf of GE HealthCare Technologies Inc. (\u201cGE HealthCare\u201d or the \u201cCompany\u201d) (NASDAQ:GEHC) investors concerning the Company\u2019s and\/or members of its senior management\u2019s possible violation of the federal securities laws and other unlawful business practices.<\/p><\/a><\/a>

\n[LEARN MORE ABOUT THE INVESTIGATION<\/a>]<\/p>

\nWhat Happened?<\/b><\/p>

\nOn April 29, 2026, GE HealthCare reported its financial results for the first quarter of 2026. Among other items, GE HealthCare reported adjusted earnings per share of $0.99, missing the consensus estimate of $1.05, and cut its full-year 2026 adjusted EPS guidance to a range of $4.80 to $5.00, down from prior guidance of $4.95 to $5.15. CEO Peter Arduini said that \u201cprofitability in the first quarter was impacted by a PDx supplier issue that has since been resolved.\u201d On this news, the price of GE HealthCare shares declined by $9.01 per share, or approximately 13%, from $68.50 per share on April 28, 2026 to close at $59.49 on April 29, 2026.<\/p>

\nWhat Should I Do?<\/b><\/p>

\nAt this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.<\/p>

\nIf you purchased or otherwise acquired GE HealthCare securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro<\/a> of Kirby McInerney LLP<\/a> by email at investigations@kmllp.com<\/a>, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.<\/p>

\n[LEARN MORE ABOUT SECURITIES CLASS ACTIONS]<\/a><\/p>

\nKirby McInerney LLP<\/a> is a New York-based plaintiffs\u2019 law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm\u2019s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP\u2019s website<\/a>.<\/p>

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p> Contacts<\/b>

\nKirby McInerney LLP\nLauren Molinaro, Esq.\n212-699-1171\nhttps:\/\/www.kmllp.com<\/a>https:\/\/securitiesleadplaintiff.com\/<\/a>investigations@kmllp.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

NEW YORK–(BUSINESS WIRE)–The law firm of Kirby McInerney LLP continues its investigation on behalf of GE HealthCare Technologies Inc. (\u201cGE HealthCare\u201d or the \u201cCompany\u201d) (NASDAQ:GEHC) investors concerning the Company\u2019s and\/or members of its senior man…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8540","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/8540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8540"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/8540\/revisions"}],"predecessor-version":[{"id":8541,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/8540\/revisions\/8541"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8540"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8540"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}